Clément N. David

1.3k total citations
22 papers, 989 citations indexed

About

Clément N. David is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Clément N. David has authored 22 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Clément N. David's work include interferon and immune responses (5 papers), Toxoplasma gondii Research Studies (4 papers) and Immune cells in cancer (4 papers). Clément N. David is often cited by papers focused on interferon and immune responses (5 papers), Toxoplasma gondii Research Studies (4 papers) and Immune cells in cancer (4 papers). Clément N. David collaborates with scholars based in United States, France and Switzerland. Clément N. David's co-authors include Leslie Freeman, Haitao Guo, W. June Brickey, Jenny P.‐Y. Ting, Sushmita Jha, Emma H. Wilson, Robert D. Junkins, Jenny P.‐Y. Ting, Karen P. McKinnon and Eric M. Bachelder and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Clément N. David

21 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clément N. David United States 11 443 423 163 154 149 22 989
Alla L. Zozulya Germany 21 710 1.6× 329 0.8× 82 0.5× 35 0.2× 393 2.6× 30 1.4k
Мikhail Pashenkov Russia 26 977 2.2× 391 0.9× 122 0.7× 40 0.3× 250 1.7× 70 1.8k
Tracey L. Papenfuss United States 20 921 2.1× 546 1.3× 154 0.9× 26 0.2× 105 0.7× 40 1.7k
Nathalie Geurts Belgium 14 277 0.6× 221 0.5× 75 0.5× 59 0.4× 75 0.5× 21 946
S. Bar‐Yehuda Israel 14 172 0.4× 430 1.0× 97 0.6× 64 0.4× 73 0.5× 19 1.1k
Fay J. Dufort United States 13 560 1.3× 503 1.2× 128 0.8× 17 0.1× 44 0.3× 22 1.1k
Serge Camelo France 20 340 0.8× 460 1.1× 112 0.7× 18 0.1× 270 1.8× 45 1.4k
Ivan Peng United States 12 535 1.2× 444 1.0× 277 1.7× 14 0.1× 84 0.6× 12 1.2k
Michelle N. Messmer United States 15 715 1.6× 540 1.3× 123 0.8× 14 0.1× 61 0.4× 18 1.3k

Countries citing papers authored by Clément N. David

Since Specialization
Citations

This map shows the geographic impact of Clément N. David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clément N. David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clément N. David more than expected).

Fields of papers citing papers by Clément N. David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clément N. David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clément N. David. The network helps show where Clément N. David may publish in the future.

Co-authorship network of co-authors of Clément N. David

This figure shows the co-authorship network connecting the top 25 collaborators of Clément N. David. A scholar is included among the top collaborators of Clément N. David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clément N. David. Clément N. David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
David, Clément N., Sohn G. Kim, Eric G. Pamer, et al.. (2024). Intestinal carbapenem-resistant Klebsiella pneumoniae undergoes complex transcriptional reprogramming following immune activation. Gut Microbes. 16(1). 2340486–2340486. 4 indexed citations
3.
Piedra-Mora, César, Linda M. Wrijil, Clément N. David, et al.. (2023). Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma. Frontiers in Veterinary Science. 10. 1225764–1225764. 2 indexed citations
4.
Piedra-Mora, César, et al.. (2022). Using Gene Expression Analysis to Understand Complex Autoimmune Skin Disease Patients: A Series of Four Canine Cutaneous Lupus Erythematosus Cases. Frontiers in Veterinary Science. 9. 778934–778934. 5 indexed citations
5.
Piedra-Mora, César, et al.. (2021). Shared inflammatory and skin-specific gene signatures reveal common drivers of discoid lupus erythematosus in canines, humans and mice. SHILAP Revista de lepidopterología. 2. 41–51. 10 indexed citations
6.
Wang, Na, Marta Vuerich, Jonathon J. Graham, et al.. (2021). Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19. iScience. 24(10). 103205–103205. 11 indexed citations
7.
8.
McGovern, Kathryn E., J. Philip Nance, Clément N. David, et al.. (2021). SPARC coordinates extracellular matrix remodeling and efficient recruitment to and migration of antigen-specific T cells in the brain following infection. Scientific Reports. 11(1). 4549–4549. 10 indexed citations
9.
10.
11.
Cheng, Ning, Robert D. Junkins, Clément N. David, et al.. (2018). A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer. JCI Insight. 3(22). 211 indexed citations
12.
Cheng, Ning, Robert D. Junkins, Clément N. David, et al.. (2018). Abstract LB-126: Nanoparticle-incorporated STING activator as an immunotherapeutic for PD-L1 resistant triple-negative breast cancer. Cancer Research. 78(13_Supplement). LB–126. 2 indexed citations
13.
Junkins, Robert D., Matthew D. Gallovic, Brandon M. Johnson, et al.. (2017). A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination. Journal of Controlled Release. 270. 1–13. 125 indexed citations
14.
Junkins, Robert D., Brandon M. Johnson, Matthew D. Gallovic, et al.. (2017). A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination. The Journal of Immunology. 198(Supplement_1). 199.14–199.14. 4 indexed citations
15.
David, Clément N., Elma S. Frias, Jenny I. Szu, et al.. (2016). GLT-1-Dependent Disruption of CNS Glutamate Homeostasis and Neuronal Function by the Protozoan Parasite Toxoplasma gondii. PLoS Pathogens. 12(6). e1005643–e1005643. 112 indexed citations
16.
David, Clément N., Elma S. Frias, Kathryn E. McGovern, et al.. (2015). Antitumor Activity of a Polypyridyl Chelating Ligand: In Vitro and In Vivo Inhibition of Glioma. ASN NEURO. 7(1). 4 indexed citations
17.
Ghang, Yoo‐Jin, Michael P. Schramm, Fan Zhang, et al.. (2013). Selective Cavitand-Mediated Endocytosis of Targeted Imaging Agents into Live Cells. Journal of the American Chemical Society. 135(19). 7090–7093. 43 indexed citations
18.
David, Clément N., J. Philip Nance, Jacqueline A. Hubbard, et al.. (2012). Stabilin-1 expression in tumor associated macrophages. Brain Research. 1481. 71–78. 25 indexed citations
19.
Nance, J. Philip, Kevin M. Vannella, Danielle Worth, et al.. (2012). Chitinase Dependent Control of Protozoan Cyst Burden in the Brain. PLoS Pathogens. 8(11). e1002990–e1002990. 56 indexed citations
20.
David, Clément N., et al.. (1978). Resistance to transplanted cancer in mice increased by live Brucella vaccine. British Journal of Cancer. 38(3). 464–467. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alla L. Zozulya Breakdown of academic impact, for papers by Мikhail Pashenkov Breakdown of academic impact, for papers by Tracey L. Papenfuss Breakdown of academic impact, for papers by Nathalie Geurts Breakdown of academic impact, for papers by S. Bar‐Yehuda Breakdown of academic impact, for papers by Fay J. Dufort Breakdown of academic impact, for papers by Serge Camelo Breakdown of academic impact, for papers by Ivan Peng Breakdown of academic impact, for papers by Michelle N. Messmer
Rankless by CCL
2026